共 74 条
[1]
Alonso-Álvarez S(2021)Cytomegalovirus in Haematological Tumours Front Immunol. 12 703256-80
[2]
Colado E(2011)Cytomegalovirus: pathogen, paradigm, and puzzle J Clin Invest. 121 1673-500
[3]
Moro-García MA(2019)Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient Infect Dis Clin North Am. 33 485-58
[4]
Alonso-Arias R(2003)Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies Biol Blood Marrow Transplant. 9 543-11
[5]
Boeckh M(1987)Cytomegalovirus and blood transfusion Blood Rev. 1 207-63
[6]
Geballe AP(2002)High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution Blood. 99 4357-53
[7]
Pande A(2008)Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors Am J Hematol. 83 649-35
[8]
Dubberke ER(1999)Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation Blood. 94 4029-91
[9]
Boeckh M(2017)Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials Clin Infect Dis. 64 87-6
[10]
Nichols WG(2015)Clinical presentation and risk factors for cytomegalovirus colitis in immunocompetent adult patients Clin Infect Dis. 60 e20-9